vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and OneSpan Inc. (OSPN). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $62.9M, roughly 1.4× OneSpan Inc.). OneSpan Inc. runs the higher net margin — 69.2% vs 22.8%, a 46.4% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 2.9%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $9.6M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -1.5%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.
FDMT vs OSPN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $62.9M |
| Net Profit | $19.4M | $43.5M |
| Gross Margin | — | 73.6% |
| Operating Margin | 17.3% | 19.9% |
| Net Margin | 22.8% | 69.2% |
| Revenue YoY | 8508900.0% | 2.9% |
| Net Profit YoY | 139.1% | 51.3% |
| EPS (diluted) | $0.43 | $1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $62.9M | ||
| Q3 25 | $90.0K | $57.1M | ||
| Q2 25 | $15.0K | $59.8M | ||
| Q1 25 | $14.0K | $63.4M | ||
| Q4 24 | $1.0K | $61.2M | ||
| Q3 24 | $3.0K | $56.2M | ||
| Q2 24 | $5.0K | $60.9M | ||
| Q1 24 | $28.0K | $64.8M |
| Q4 25 | $19.4M | $43.5M | ||
| Q3 25 | $-56.9M | $6.5M | ||
| Q2 25 | $-54.7M | $8.3M | ||
| Q1 25 | $-48.0M | $14.5M | ||
| Q4 24 | — | $28.8M | ||
| Q3 24 | $-43.8M | $8.3M | ||
| Q2 24 | $-35.0M | $6.6M | ||
| Q1 24 | $-32.4M | $13.5M |
| Q4 25 | — | 73.6% | ||
| Q3 25 | — | 73.6% | ||
| Q2 25 | — | 73.5% | ||
| Q1 25 | — | 74.3% | ||
| Q4 24 | — | 74.0% | ||
| Q3 24 | — | 73.9% | ||
| Q2 24 | — | 66.2% | ||
| Q1 24 | — | 73.1% |
| Q4 25 | 17.3% | 19.9% | ||
| Q3 25 | -67983.3% | 14.4% | ||
| Q2 25 | -396373.3% | 17.6% | ||
| Q1 25 | -383007.1% | 27.1% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | -1704400.0% | 20.0% | ||
| Q2 24 | -849120.0% | 12.5% | ||
| Q1 24 | -136200.0% | 21.8% |
| Q4 25 | 22.8% | 69.2% | ||
| Q3 25 | -63195.6% | 11.4% | ||
| Q2 25 | -364386.7% | 13.9% | ||
| Q1 25 | -342657.1% | 22.9% | ||
| Q4 24 | — | 47.1% | ||
| Q3 24 | -1461433.3% | 14.7% | ||
| Q2 24 | -699060.0% | 10.8% | ||
| Q1 24 | -115717.9% | 20.8% |
| Q4 25 | $0.43 | $1.13 | ||
| Q3 25 | $-1.01 | $0.17 | ||
| Q2 25 | $-0.98 | $0.21 | ||
| Q1 25 | $-0.86 | $0.37 | ||
| Q4 24 | — | $0.73 | ||
| Q3 24 | $-0.79 | $0.21 | ||
| Q2 24 | $-0.63 | $0.17 | ||
| Q1 24 | $-0.66 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $70.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $271.8M |
| Total Assets | $566.7M | $397.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $70.5M | ||
| Q3 25 | $305.1M | $85.6M | ||
| Q2 25 | $293.2M | $92.9M | ||
| Q1 25 | $321.4M | $105.2M | ||
| Q4 24 | $424.9M | $83.2M | ||
| Q3 24 | $501.9M | $77.5M | ||
| Q2 24 | $541.9M | $63.8M | ||
| Q1 24 | $525.9M | $63.9M |
| Q4 25 | $505.7M | $271.8M | ||
| Q3 25 | $369.0M | $238.3M | ||
| Q2 25 | $420.9M | $242.5M | ||
| Q1 25 | $469.7M | $231.1M | ||
| Q4 24 | $510.6M | $212.5M | ||
| Q3 24 | $552.9M | $194.6M | ||
| Q2 24 | $588.3M | $178.6M | ||
| Q1 24 | $600.6M | $170.9M |
| Q4 25 | $566.7M | $397.7M | ||
| Q3 25 | $424.0M | $343.5M | ||
| Q2 25 | $473.6M | $357.1M | ||
| Q1 25 | $515.7M | $333.8M | ||
| Q4 24 | $560.4M | $338.7M | ||
| Q3 24 | $604.0M | $289.3M | ||
| Q2 24 | $620.1M | $286.9M | ||
| Q1 24 | $629.9M | $277.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $12.6M |
| Free Cash FlowOCF − Capex | $28.5M | $9.6M |
| FCF MarginFCF / Revenue | 33.5% | 15.3% |
| Capex IntensityCapex / Revenue | 0.1% | 4.7% |
| Cash ConversionOCF / Net Profit | 1.47× | 0.29× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $50.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $12.6M | ||
| Q3 25 | $-46.5M | $11.3M | ||
| Q2 25 | $-43.4M | $6.2M | ||
| Q1 25 | $-47.8M | $29.4M | ||
| Q4 24 | $-134.6M | $12.4M | ||
| Q3 24 | $-29.4M | $14.0M | ||
| Q2 24 | $-30.2M | $2.3M | ||
| Q1 24 | $-29.1M | $27.0M |
| Q4 25 | $28.5M | $9.6M | ||
| Q3 25 | $-46.6M | $8.8M | ||
| Q2 25 | $-43.4M | $4.4M | ||
| Q1 25 | $-48.4M | $27.7M | ||
| Q4 24 | $-138.4M | $10.5M | ||
| Q3 24 | $-31.2M | $12.0M | ||
| Q2 24 | $-30.6M | $26.0K | ||
| Q1 24 | $-29.8M | $23.9M |
| Q4 25 | 33.5% | 15.3% | ||
| Q3 25 | -51765.6% | 15.4% | ||
| Q2 25 | -289620.0% | 7.3% | ||
| Q1 25 | -345635.7% | 43.8% | ||
| Q4 24 | -13837100.0% | 17.1% | ||
| Q3 24 | -1038966.7% | 21.4% | ||
| Q2 24 | -611840.0% | 0.0% | ||
| Q1 24 | -106421.4% | 36.9% |
| Q4 25 | 0.1% | 4.7% | ||
| Q3 25 | 101.1% | 4.4% | ||
| Q2 25 | 440.0% | 3.1% | ||
| Q1 25 | 4507.1% | 2.6% | ||
| Q4 24 | 378600.0% | 3.2% | ||
| Q3 24 | 59266.7% | 3.5% | ||
| Q2 24 | 6980.0% | 3.7% | ||
| Q1 24 | 2535.7% | 4.7% |
| Q4 25 | 1.47× | 0.29× | ||
| Q3 25 | — | 1.74× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 0.35× | ||
| Q1 24 | — | 2.00× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
OSPN
| Transferred At Point In Time | $32.7M | 52% |
| Subscription | $21.1M | 34% |
| Maintenance Support And Other | $9.2M | 15% |
